(Q45019454)

8 December 2017

title

The Bosentan Patient Registry: long-term survival in pulmonary arterial hypertension (English)

1 reference

8 December 2017

main subject

arterial hypertension

0 references

1 reference

A Keogh

1

1 reference

8 December 2017

G Strange

2

1 reference

8 December 2017

K McNeil

3

1 reference

8 December 2017

T J Williams

4

1 reference

8 December 2017

E Gabbay

5

1 reference

8 December 2017

S Proudman

6

1 reference

8 December 2017

R G Weintraub

7

1 reference

8 December 2017

J Wlodarczyk

8

1 reference

8 December 2017

B Dalton

9

1 reference

8 December 2017

publication date

1 March 2011

1 reference

Internal Medicine Journal

8 December 2017

published in

1 reference

8 December 2017

volume

41

1 reference

8 December 2017

issue

3

1 reference

8 December 2017

page(s)

227-234

1 reference

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02139.X

Quality of life in pulmonary arterial hypertension: improvement and maintenance with bosentan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02139.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02139.X

The endothelin system in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02139.X

Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02139.X

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02139.X

Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02139.X

Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02139.X

Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02139.X

Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02139.X

Results of European post-marketing surveillance of bosentan in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02139.X

Public funding of bosentan for the treatment of pulmonary artery hypertension in Australia: cost effectiveness and risk sharing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02139.X

Survival with first-line bosentan in patients with primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02139.X

Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02139.X

Systemic sclerosis associated pulmonary hypertension: improved survival in the current era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02139.X

Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02139.X

Pulmonary arterial hypertension in France: results from a national registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02139.X

Primary pulmonary hypertension. A national prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02139.X

Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02139.X

Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02139.X

10.1111/J.1445-5994.2009.02139.X

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference